The U.S. next generation sequencing market size was valued at USD 2.85 billion in 2025 and is predicted to hit around USD ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Mr. Han may continue to purchase the Company’s ADSs through open-market transactions, privately negotiated transactions or block trades, or other legally permissible means, depending on market ...
Healthcare Asia Magazine on MSN
Next-generation sequencing services market to reach $8.77b by 2030
The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market ...
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
IRVING, Texas, Jan. 5, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
The ongoing Italian clinical and research FPG500 program is designed to tailor matched targeted therapies (MTTs) based on "biomarkers predictive of response identified by comprehensive genome profiling ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing evidence on the utility of ctDNA testing.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results